Daniel A. Vorobiof, MD, the chief medical director of Belong.Life, discusses the impact of financial toxicity on patients with cancer.
Financial toxicity has become a growing concern for several patients with cancer, as well as their caregivers, says Vorobiof. As treatment costs continue to rise, Vorobiof says that financial toxicity is a challenge that can no longer be ignored. A cancer diagnosis is often accompanied by substantial financial burden, and although this is not a new issue, it must be addressed, Vorobiof says.
Real-world data from several clinical studies indicate that financial toxicity is a major factor that impacts outcomes and the quality of life of patients, spanning different tumor types and treatments received, Vorobiof concludes.